Evidence map›Paper›PMID 22103608›Full record

ReviewBiomarkers in medicine2011

Energy metabolism in nuclear reprogramming.

Clifford D L Folmes, Timothy J Nelson, Andre Terzic

Abstract readReview
In one paragraph

Review in Biomarkers in medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Role of Diet in Stem and Cancer Stem Cells.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Malignancy prediction among tissues from Oral SCC patients including neck invasions: aMetabolomics : Official journal of the Metabolomic Society · 2020
    Article
  7. Article
  8. Article
  9. Pharmacological Regulation of Oxidative Stress in Stem Cells.Oxidative medicine and cellular longevity · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Metabolic determinants of embryonic development and stem cell fate.Reproduction, fertility, and development · 2014
    Review
  18. Cancer stem cell theory and the warburg effect, two sides of the same coin?International journal of molecular sciences · 2014
    Article
  19. Metabostemness: a new cancer hallmark.Frontiers in oncology · 2014
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Clifford D L FolmesCenter for Regenerative Medicine and Marriott Heart Disease Research Program, MN, USA.
Timothy J Nelson
Andre Terzic
Center for Neuroscience and Regenerative Medicine · USMayo Clinic · US

Funding

Cardioprotective Repair through CardiopoiesisR01HL083439 · NHLBI · MAYO CLINIC ROCHESTER · PI TERZIC, ANDRE · 2006 to 2010
$1.8M
NHLBI NIH HHS R01 HL083439
6 · The paper itself

Abstract

Nuclear reprogramming with stemness factors enables resetting of somatic differentiated tissue back to the pluripotent ground state. Recent evidence implicates mitochondrial restructuring and bioenergetic plasticity as key components underlying execution of orchestrated dedifferentiation and derivation of induced pluripotent stem cells. Aerobic to anaerobic transition of somatic oxidative energy metabolism into a glycolytic metabotype promotes proficient reprogramming, establishing a novel regulator of acquired stemness. Metabolomic profiling has further identified specific metabolic remodeling traits defining lineage redifferentiation of pluripotent cells. Therefore, mitochondrial biogenesis and energy metabolism comprise a vital axis for biomarker discovery, intimately reflecting the molecular dynamics fundamental for the resetting and redirection of cell fate.

Indexed as

Cellular ReprogrammingBiomarkersEnergy MetabolismGlycolysisHumansInduced Pluripotent Stem CellsMetabolomicsMitochondriaBiomarkers

Identifiers

PMID22103608
PMCPMC3477517
OpenAlexW2011189226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.